Potential Biomarkers of Preeclampsia: Inverse Correlation between Hydrogen Peroxide and Nitric Oxide Early in Maternal Circulation and at Term in Placenta of Women with Preeclampsia

Placenta

Volumn 30, Issue 4, 2009, Pages 342-347

  Aris, A ^a,b   Benali, S ^b   Ouellet, A ^a   Moutquin, J M ^a   Leblanc, S ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b Laboratory of Research in Reproductive and Gestational Health   (Canada)

Author keywords

Biomarkers; Hydrogen peroxide (H2O2); Nitric oxide (NO); Oxidative stress; Placenta; Preeclampsia

Indexed keywords

BIOLOGICAL MARKER; HYDROGEN PEROXIDE; NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTROPHOBLAST; DELIVERY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOTHER; PLACENTA; PREDICTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SERUM; SYNTHESIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; HYDROGEN PEROXIDE; INFANT, NEWBORN; NITRIC OXIDE; OXIDATIVE STRESS; PARTURITION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS; YOUNG ADULT;

EID: 62249111357     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.01.003     Document Type: Article

References (39)

1. Roberts J.M., and Lain K.Y. Recent insights into the pathogenesis of pre-eclampsia. Placenta 23 (2002) 359-372
2. Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102 (2003) 181-192
3. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
4. Kharfi A., Giguere Y., Sapin V., Masse J., Dastugue B., and Forest J.C. Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem 36 (2003) 323-331
5. Lyall F., and Myatt L. The role of the placenta in pre-eclampsia-a workshop report. Placenta 23 (2002) S142-S145
6. Granger J.P., Alexander B.T., Llinas M.T., Bennett W.A., and Khalil R.A. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9 (2002) 147-160
7. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
8. Khalil R.A., and Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283 (2002) R29-R45
9. Kharfi A., Giguère Y., De Grandpré P., Moutquin J.M., and Forest J.C. Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies. Clin Biochem 38 8 (2005) 717-721
10. 2 on placental hCG secretion: implications for oxidative stress in preeclampsia. Clin Biochem 40 (2007) 94-97
11. Ariza A.C., Bobadilla N.A., and Halhali A. Endothelin 1 and angiotensin II in preeclampsia. Rev Invest Clin 59 1 (2007) 48-56
12. Agarwal A., Gupta S., and Sharma R.K. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3 (2005) 28
13. Tsukimori K., Komatsu H., Fukushima K., Kaku T., Nakano H., and Wake N. Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-alpha, and placental apoptosis. Am J Hypertens 21 4 (2008) 477-481
14. Schiessl B., Mylonas I., Hantschmann P., Kuhn C., Schulze S., Kunze S., et al. Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem 53 12 (2005) 1441-1449
15. Cederbaum S.D., Yu H., Grody W.W., Kern R.M., Yoo P., and Iyer R.K. Arginases I and II: do their functions overlap?. Mol Genet Metab 81 (2004) S38-S44
16. Morris Jr. S.M. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 22 (2002) 87-105
17. Ishakawa T., Harada T., Koi H., Kubota T., Azuma H., and Aso T. Identification of arginase in human placental villi. Placenta 28 2-3 (2007) 133-138
18. Bhatnagar S., Bhattacharjee J., Vaid M., Madan T., Trivedi S.S., and Sarma P.U. Inducible nitric oxide synthase (iNOS) gene polymorphism in pre-eclampsia: a pilot study in north India. Aust N Z J Obstet Gynaecol 47 6 (2007) 477-482
19. Vural P. Nitric oxide/endothelin-1 in preeclampsia. Clin Chim Acta 317 1-2 (2002) 65-70
20. Shaamash A.H., Elsnosy E.D., Makhlouf A.M., Zakhari M.M., Ibrahim O.A., and ElDien H.M. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 68 (2000) 207-214
21. Sandrim V.C., Palei A.C., Metzger I.F., Gomes V.A., Cavalli R.C., and Tanus-Santos J.E. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension 52 2 (2008) 402-407
22. Schonfelder G., Fuhr N., Hadzidiakos D., John M., Hopp H., and Paul M. Preeclampsia is associated with loss of neuronal nitric oxide synthase expression in vascular smooth muscle cells of the human umbilical cord. Histopathology 44 (2004) 116-128
23. Orange S.J., Painter D., Horvath J., Yu B., Trent R., and Hennessy A. Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin Exp Pharmacol Physiol 30 5-6 (2003) 376-381
24. Mayhew T.M., and Burton G.J. Methodological problems in placental morphometry: apologia for the use of stereology based on sound sampling practice. Placenta 9 (1988) 565-581
25. Huang X., Huang H., Dong M., Yao Q., and Wang H. Serum and placental interleukin-18 are elevated in preeclampsia. J Reprod Immunol 65 1 (2005) 77-87
26. Kliman H.J., Nestler J.E., Sermasi E., Sanger J.M., and Strauss III J.F. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118 (1986) 1567-1582
27. Hallmann A., Klimek J., Masaoka M., Kaminski M., Kedzior J., Majczak A., et al. Partial characterization of human choriocarcinoma cell line JAR cells in regard to oxidative stress. Acta Biochim Pol 51 (2004) 1023-1038
28. Halliwell B., Clement M.V., and Long L.H. Hydrogen peroxide in the human body. FEBS Lett 486 1 (2000) 10-13
29. Varma S.D., and Devamanoharan P.S. Hydrogen peroxide in human blood. Free Radic Res Commun 14 (1991) 125-131
30. Lacy F., O'Connor D.T., and Schmid-Schonbein G.W. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16 (1998) 291-303
31. Deskur E., Przywarska I., Dylewicz P., Szczesniak L., Rychlewski T., Wilk M., et al. Exercise-induced increase in hydrogen peroxide plasma levels is diminished by endurance training after myocardial infarction. Int J Cardiol 67 (1998) 219-224
32. Baylis C., and Vallance P. Measurement of nitrite and nitrate levels in plasma and urine - what does this measure tell us about the activity of the endogenous nitric oxide system?. Curr Opin Nephrol Hypertens 7 (1998) 59-62
33. Kleinbongard P., Rassaf T., Dejam A., Kerber S., and Kelm M. Griess method for nitrite measurement of aqueous and protein-containing samples. Methods Enzymol 359 (2002) 158-168
34. Myatt L., and Cui X. Oxidative stress in the placenta. Histochem Cell Biol 122 (2004) 369-382
35. Noris M., Todeschini M., Cassis P., Pasta F., Cappellini A., Bonazzola S., et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 43 3 (2004) 614-622
36. Culcasi M., Lafon-Cazal M., Pietri S., and Bockaert J. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J Biol Chem 269 17 (1994) 12589-12593
37. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271 5, Part 1 (1996) C1424-C1437
38. Altun Z.S., Uysal S., Guner G., Yilmaz O., and Posaci C. Effects of oral L-arginine supplementation on blood pressure and asymmetric dimethylarginine in stress-induced preeclamptic rats. Cell Biochem Funct 26 5 (2008) 648-653
39. 2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 26 9 (2006) 2035-2042